Advertisement
Screener

Processa Pharmaceuticals, Inc. (PCSA) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number

2.8 / 5 stars · 68/120 Roast Me

Processa Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number

Processa Pharmaceuticals, Inc. (PCSA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 136.37 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-08-14

  • 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 136.37K shares.
  • 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 136.37K shares.
  • 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 136.37K shares.
  • 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 112.00 shares; Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed 2.75K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, NumberShare-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed
2026-06-30136.37K shares
10-Q · filed 2026-08-14
2026-03-31136.37K shares
10-Q · filed 2026-05-07
2025-12-31136.37K shares
10-Q · filed 2026-08-14
2024-12-31112.00 shares
10-K · filed 2026-03-18		2.75K shares
10-K · filed 2025-03-20
2023-12-31302.00 shares
10-K · filed 2026-03-18		6.99K shares
10-K · filed 2024-03-29
2022-12-318.94K shares
10-K · filed 2025-03-20
2021-12-318.94K shares
10-K · filed 2024-03-29		178.50K shares
10-K · filed 2022-03-30
2020-12-31152.81K shares
10-K · filed 2023-03-30
2019-12-31176.96K shares
10-K · filed 2022-03-30
2019-09-301.29M shares
10-Q · filed 2019-11-14
2019-06-301.29M shares
10-Q · filed 2019-08-14
2018-12-3154.91K shares
10-K · filed 2021-03-25		384.40K shares
10-K · filed 2019-03-28
2018-09-30334.40K shares
10-Q · filed 2019-11-14		33.40K shares
10-Q · filed 2018-11-14
2017-06-30237.50K shares
10-Q · filed 2017-10-04
2017-03-31247.50K shares
10-Q · filed 2017-10-04
2016-12-31269.50K shares
10-Q · filed 2017-11-20
2016-09-30269.50K shares
10-Q · filed 2017-09-08
2016-06-30357.00K shares
10-Q · filed 2017-08-30
2016-03-31357.00K shares
10-Q · filed 2017-08-07
2015-12-31591.17K shares
10-K · filed 2017-09-25
2015-09-30771.17K shares
10-Q · filed 2015-12-01
2015-06-30773.50K shares
10-Q · filed 2015-08-19
2015-03-311.24M shares
10-Q · filed 2015-05-15
2014-12-311.25M shares
10-K · filed 2017-09-25
2014-09-301.35M shares
10-Q · filed 2014-11-13
2014-06-301.41M shares
10-Q · filed 2014-08-19
2014-03-311.40M shares
10-Q · filed 2014-05-14
2013-12-311.32M shares
10-K · filed 2017-06-19
2013-09-301.02M shares
10-Q · filed 2013-11-08
2013-06-301.03M shares
10-Q/A · filed 2013-09-06
2012-12-311.02M shares
10-K · filed 2015-04-14
2011-12-31300.00K shares
10-K · filed 2014-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMARIN CORP PLC\UK (AMRN)$0.005B-247.24
Xenetic Biosciences, Inc. (XBIO)United States$0.006B
ProPhase Labs, Inc. (PRPH)United States$0.006B-0.06
Dermata Therapeutics, Inc. (DRMA)United States$0.005B-0.62
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)United States$0.005B
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90
Pulmatrix, Inc. (PULM)United States$0.006B
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
Ernexa Therapeutics Inc. (ERNA)United States$0.006B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
Advertisement